Stern K. Adam

Biography

Adam K. Stern has served as a member of our board of directors since December 2014. Mr. Stern has been the head Private Equity Banking at Aegis Capital Corp. and CEO of SternAegis Ventures since 2012. Prior to Aegis, from 1997 to November 2012, he was with Spencer Trask Ventures, Inc., most recently as a Senior Managing Director, where he managed the structured finance group focusing primarily on the technology and life science sectors. Mr. Stern held increasingly responsible positions from 1989 to 1997 with Josephthal & Co., Inc., members of the New York Stock Exchange, where he served as Senior Vice President and Managing Director of Private Equity Marketing. He has been a FINRA licensed securities broker since 1987 and a General Securities Principal since 1991. Mr. Stern is a director of Matinas Biopharma Holdings, Inc. Mr. Stern is a former director of InVivo Therapeutics Holdings Corp. (NASDAQ Global Market: NVIV), Organovo Holdings, Inc. (NASDAQ Global Market: ONVO), LabStyle Innovations Corporation (NASDAQ Capital Market: DRIO) and PROLOR Biotech Ltd., which was sold to Opko Health, Inc. (NASDAQ Global Select: OPK) for approximately $600 million in 2013. Mr. Stern holds a Bachelor of Arts degree with honors from The University of South Florida in Tampa. We believe Mr. Stern is qualified to serve on our board of directors because of his extensive experience in corporate finance with special emphasis on the life science industries.

Research Interest

Pharmaceuticals